Venetoclax for Prevention of Differentiation Syndrom in Acute Promyelocytic Leukemia Patients

NCT06544109 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ENROLLING_BY_INVITATION

Status

98

Enrollment

OTHER

Sponsor class

Conditions

Acute Promyelocytic Leukemia

Interventions

DRUG: venetoclax

Sponsor

The First Affiliated Hospital of Soochow University